Angiopoietin-like protein 3 markedly enhanced in the hyperlipidemia related proteinuria

[1]  D. Rader,et al.  Role of angiopoietin-like 3 (ANGPTL3) in regulating plasma level of low-density lipoproteins , 2018 .

[2]  Chad A. Cowan,et al.  Role of angiopoietin-like 3 (ANGPTL3) in regulating plasma level of low-density lipoprotein cholesterol. , 2018, Atherosclerosis.

[3]  A. Grover,et al.  Correlation of compliance to statin therapy with lipid profile and serum HMGCoA reductase levels in dyslipidemic patients , 2016, Indian heart journal.

[4]  Rui Zhang,et al.  Exendin-4 Ameliorates Lipotoxicity-induced Glomerular Endothelial Cell Injury by Improving ABC Transporter A1-mediated Cholesterol Efflux in Diabetic apoE Knockout Mice* , 2016, The Journal of Biological Chemistry.

[5]  L. Donini,et al.  Effects of angiopoietin-like protein 3 deficiency on postprandial lipid and lipoprotein metabolism1[S] , 2016, Journal of Lipid Research.

[6]  Jonathan C. Cohen,et al.  Hepatic ANGPTL3 regulates adipose tissue energy homeostasis , 2015, Proceedings of the National Academy of Sciences.

[7]  I. Pastan,et al.  Podocyte injury-driven lipid peroxidation accelerates the infiltration of glomerular foam cells in focal segmental glomerulosclerosis. , 2015, The American journal of pathology.

[8]  Jonathan C. Cohen,et al.  ANGPTL3 blockade with a human monoclonal antibody reduces plasma lipids in dyslipidemic mice and monkeys1[S] , 2015, Journal of Lipid Research.

[9]  Michiyasu Takeyama,et al.  Human apolipoprotein B transgenic SHR/NDmcr-cp rats show exacerbated kidney dysfunction , 2015, Experimental animals.

[10]  L. Hao,et al.  Severe hypertriglyceridemia and hypercholesterolemia accelerating renal injury: a novel model of type 1 diabetic hamsters induced by short-term high-fat / high-cholesterol diet and low-dose streptozotocin , 2015, BMC Nephrology.

[11]  X. Zha,et al.  A vital role for Angptl3 in the PAN-induced podocyte loss by affecting detachment and apoptosis in vitro , 2015, BMC Nephrology.

[12]  Duan Ma,et al.  A novel role of angiopoietin-like-3 associated with podocyte injury , 2015, Pediatric Research.

[13]  Yuanxiu Huang,et al.  Epidemiology of dyslipidemia in Chinese adults: meta-analysis of prevalence, awareness, treatment, and control , 2014, Population Health Metrics.

[14]  Mahboob Rahman,et al.  Relation of serum lipids and lipoproteins with progression of CKD: The CRIC study. , 2014, Clinical journal of the American Society of Nephrology : CJASN.

[15]  M. Tonelli,et al.  KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient. , 2014, Kidney international.

[16]  H. J. Kim,et al.  Amelioration of nephropathy with apoA-1 mimetic peptide in apoE-deficient mice. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[17]  X. Zha,et al.  Angiopoietin-like protein 3 regulates the motility and permeability of podocytes by altering nephrin expression in vitro. , 2010, Biochemical and biophysical research communications.

[18]  R. Bohle,et al.  Atherosclerosis, inflammation and lipoprotein glomerulopathy in kidneys of apoE-/-/LDL-/- double knockout mice , 2010, BMC nephrology.

[19]  Zhihe Liu,et al.  Apolipoprotein L1, a Novel Bcl-2 Homology Domain 3-only Lipid-binding Protein, Induces Autophagic Cell Death* , 2008, Journal of Biological Chemistry.

[20]  Kenichi Yoshida,et al.  ANGPTL3 Decreases Very Low Density Lipoprotein Triglyceride Clearance by Inhibition of Lipoprotein Lipase* , 2002, The Journal of Biological Chemistry.

[21]  B. Kasiske,et al.  Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats. , 1988, Kidney international.